Recapitulate development to promote axonal regeneration: good or bad approach?

Marie T Filbin1

  • 1Department of Biological Sciences, Hunter College, City University of New York, 695 Park Avenue, New York, NY 10021, USA. filbin@genectr.hunter.cuny.edu

Insights

Adult mammalian central nervous system (CNS) axons fail to regenerate due to molecular inhibitors. Understanding these inhibitors and developmental changes offers therapeutic targets for CNS injury and regeneration.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Axon regeneration differs significantly between neonatal and adult mammalian central nervous system (CNS).
  • Recent advances have elucidated molecular mechanisms underlying the failure of adult CNS axon regeneration.

Purpose of the Study:

  • To review molecular inhibitors of adult CNS axon regeneration.
  • To discuss signaling pathways and developmental changes impacting regeneration.
  • To explore therapeutic strategies for promoting CNS repair.

Main Methods:

  • Literature review of molecular mechanisms of axonal growth inhibition.
  • Analysis of developmental differences between neonatal and adult CNS.
  • Evaluation of therapeutic interventions targeting regeneration inhibitors.

Main Results:

  • Identification of specific molecular inhibitors and their receptors in the adult CNS.
  • Understanding of signal transduction pathways responsible for regeneration blockade.
  • Insights into developmental plasticity that permits regeneration in younger CNS.

Conclusions:

  • Knowledge of inhibitory molecules and pathways provides novel targets for drug development.
  • Further research is needed to determine optimal therapeutic combinations for CNS injury.
  • Understanding developmental differences is key to unlocking regenerative potential in the adult CNS.